Stockscreener 앱 받기
27.92
2.41%
-0.69
전일 마감가:
$28.61
열려 있는:
$29
하루 거래량:
212.36K
Relative Volume:
0.87
시가총액:
$1.19B
수익:
-
순이익/손실:
$-161.15M
주가수익비율:
-7.5157
EPS:
-3.7149
순현금흐름:
$-138.61M
1주 성능:
-7.89%
1개월 성능:
+31.88%
6개월 성능:
+74.50%
1년 성능:
+0.00%
1일 변동 폭
$27.76
$29.25
1주일 범위
$26.39
$32.08
52주 변동 폭
$12.24
$33.28
Maplight Therapeutics Inc Stock (MPLT) Company Profile
명칭
Maplight Therapeutics Inc
전화
650-839-4360
주소
800 CHESAPEAKE DRIVE, REDWOOD CITY
Compare MPLT vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MPLT
Maplight Therapeutics Inc
|
27.92 | 1.19B | 0 | -161.15M | -138.61M | -3.7149 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Maplight Therapeutics Inc Stock (MPLT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-08 | 개시 | Needham | Buy |
| 2026-04-07 | 개시 | TD Cowen | Buy |
| 2026-03-19 | 개시 | Canaccord Genuity | Buy |
| 2025-11-21 | 개시 | Jefferies | Buy |
| 2025-11-21 | 개시 | Leerink Partners | Outperform |
| 2025-11-21 | 개시 | Morgan Stanley | Overweight |
| 2025-11-21 | 개시 | Stifel | Buy |
모두보기
Maplight Therapeutics Inc 주식(MPLT)의 최신 뉴스
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by HC Wainwright - MarketBeat
HC Wainwright Initiates Coverage on MapLight Therapeutics With Buy Rating, $45 Price Target - Moomoo
Christopher Kroeger to sell MPLT shares (NASDAQ: MPLT) per Form 144 filing - Stock Titan
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 5.5%Here's What Happened - MarketBeat
36,371 shares proposed sale via Jefferies for Maplight Therapeutics (NASDAQ: MPLT) - Stock Titan
Erin Foff sells 3,213 MPLT shares via Jefferies (MPLT) - Stock Titan
[144] MapLight Therapeutics, Inc. SEC Filing - Stock Titan
27,834-share proposed sale by Maplight Therapeutics (NASDAQ: MPLT) - Stock Titan
This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of April - Yahoo Finance
MapLight completes enrollment in two phase 2 CNS trials By Investing.com - Investing.com South Africa
MapLight completes enrollment in two phase 2 CNS trials - Investing.com
MapLight Therapeutics Completes Enrollment in ZEPHYR Phase 2 Trial for Schizophrenia and Final Patient Visit in IRIS Phase 2 Trial for Autism Spectrum Disorder - Quiver Quantitative
MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results - The Manila Times
MapLight lines up schizophrenia and autism trial results by mid-August - Stock Titan
MPLT SEC FilingsMapLight Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
MapLight Therapeutics chief discovery officer sells $1.35 million in stock By Investing.com - Investing.com India
MapLight Therapeutics CAAO Jonathan Gillis sells $2.09 million stock By Investing.com - Investing.com India
MapLight Therapeutics CAAO Jonathan Gillis sells $2.09 million stock - Investing.com
Jonathan Gillis Sells 51,900 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock - MarketBeat
Anatol Kreitzer Sells 45,422 Shares of Maplight Therapeutics (NASDAQ:MPLT) Stock - MarketBeat
Insider Selling: Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 17,935 Shares of Stock - MarketBeat
Maplight Therapeutics Insider Sold Shares Worth $1,347,066, According to a Recent SEC Filing - marketscreener.com
MapLight Therapeutics Announces Board Refresh and New Nominees - TipRanks
69,835 MapLight (MPLT) shares sold under 10b5-1 trading plan - Stock Titan
MapLight Therapeutics (NASDAQ: MPLT) CDO sells 45,422 shares under 10b5-1 plan - Stock Titan
MapLight Therapeutics (MPLT) board shifts as two directors exit, two nominated - Stock Titan
[ARS] MapLight Therapeutics, Inc. SEC Filing - Stock Titan
MapLight Therapeutics (NASDAQ: MPLT) details 2026 director and auditor votes - Stock Titan
MapLight's psychosis drug could deliver billion-dollar upside, says analyst - MSN
Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN
MPLT (NASDAQ) notice: 45,422 RSU shares proposed for resale - Stock Titan
Insider sale: 3,590 shares reported for MPLT (NASDAQ: MPLT) - Stock Titan
Potential Bristol Myers rival MapLight seeks $250M in U.S. IPO - MSN
We're Hopeful That MapLight Therapeutics (NASDAQ:MPLT) Will Use Its Cash Wisely - Yahoo Finance
Maplight Therapeutics (NASDAQ:MPLT) Hits New 52-Week HighWhat's Next? - MarketBeat
Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat
What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data - AOL.com
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Up 12.8%Still a Buy? - MarketBeat
MapLight Therapeutics, Inc.Common Stock (Nasdaq:MPLT) Stock Quote - The Chronicle-Journal
Maplight Therapeutics (NASDAQ:MPLT) Shares Gap DownHere's Why - MarketBeat
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
What macro factors move MapLight Therapeutics (MPLT) stock most (Trend Weakens) 2026-04-20Late Breakout - Cổng thông tin điện tử tỉnh Lào Cai
TD Cowen Initiates on MapLight (MPLT); Says It’s Undervalued on Schizophrenia Alone - Insider Monkey
MapLight Therapeutics (MPLT): The best healthcare stock insiders are buying - MSN
Maplight Therapeutics, Inc.'s (NASDAQ:MPLT) Lock-Up Period To Expire on April 27th - MarketBeat
5 Must-Buy Small Cap Stocks to Buy - Insider Monkey
MapLight Therapeutics CAAO sells $95k in MPLT stock By Investing.com - Investing.com India
MapLight Therapeutics Leadership Quietly Unloads a Wave of Shares - TipRanks
MapLight Therapeutics CFO Setia Vishwas sells $78,572 in shares - Investing.com
MapLight Therapeutics CFO Setia Vishwas sells $78,572 in shares By Investing.com - Investing.com India
Maplight Therapeutics Inc (MPLT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):